Search

everythinglearnresearchcommunity

for

Search:↓

Completing a 14-day proxalutamide treatment significantly lowers death rates in hospitalized COVID-19 patients.

Nailfold dermoscopy is a simple, cheap way to check blood vessel changes in COVID-19 patients.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

The G allele of IFITM3 rs12252 is linked to more severe COVID-19.

The MATH+ protocol aims to improve COVID-19 outcomes using a combination of specific treatments.

Quality of life improved after COVID-19, but ongoing health support is needed.

Zinc acetate hydrate may help reduce fatigue and hair loss in post-COVID-19 patients.

University students in Egypt experienced high stress during COVID-19's third wave, with negative coping mechanisms being more common.

Icosapent ethyl may help treat long-lasting symptoms after COVID-19.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Cepharanthine is safe but not effective in significantly reducing COVID-19 recovery time.

Beau's lines on fingernails might indicate past severe COVID-19 and risk of reinfection.

Cepharanthine is safe but not clearly effective in speeding up COVID-19 recovery.

Hormonal status from androgen deprivation therapy may affect COVID-19 severity in men.

Certain genes and nutrients like vitamin D, zinc, and omega fatty acids affect COVID-19 severity and infection risk.

Women, younger age, and low BMI increase the risk of long COVID symptoms.

More research is needed to understand sex and racial differences in long COVID.

Physical activity increased, but sedentary behavior also rose, especially in men.

Experts recommend a team-based approach to treat patients with long-lasting COVID-19 symptoms and emphasize the need for ongoing research.

Continued vaccine and drug development is crucial due to new virus variants and regional infection spikes.

Hydroxychloroquine, nitazoxanide, and ivermectin were similarly effective in treating early COVID-19.

Most severe COVID-19 patients in Mexico experienced long-lasting symptoms that worsened their quality of life.

Africa's low COVID-19 rates may be linked to early measures and possibly higher estrogen levels in women.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

COVID-19 infection is highly related to increased hair loss, especially in women.

Two existing drugs may help treat COVID-19 by inhibiting a key viral protein.

Cepharanthine may help treat COVID-19 by targeting similar pathways as other inflammatory diseases.

The COVID-19 pandemic increased the use of teledermatology to treat skin conditions in low-income areas, despite challenges like poor photo quality.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

COVID-19 may cause temporary hair loss, which usually gets better on its own, but reducing stress and managing health issues might help recovery.